PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
03-Oct-2024 Heidelberg Pharma: New Clinical Data on Lead ADC Candidate HDP-101 Presented at IMS 2024 Demonstrating Complete Remission in One Patient Heidelberg Pharma
03-Oct-2024 First Clinical Data on Ornithine Transcarbamylase Deficiency Program to be presented at the European Society of Gene & Cell Therapy 31st Annual Meeting 2024 Bloomsbury Genetic Therapies Limited
01-Oct-2024 New Pharmanovia Study Results Reveal Chloral Hydrate Noticeably Improves Severe Insomnia Within Two Weeks Pharmanovia
01-Oct-2024 Galapagos receives transparency notification from EcoR1 Capital Galapagos
01-Oct-2024 Neuraxpharm expands operations into the Middle East Neuraxpharm
01-Oct-2024 CSL Behring granted positive reimbursement recommendation for Haemophilia B Gene Therapy, HEMGENIX® in Spain CSL
01-Oct-2024 Abzena Expands Partnership with ProteoNic to Include 2G UNic® Technology as Standard Offering for All Customers ProteoNic
01-Oct-2024 AlzeCure's abstract on ACD856's anti-inflammatory effects to be presented at a leading Alzheimer's conference AlzeCure Pharma AB (publ)
01-Oct-2024 AstronauTx appoints Jane Rhodes as Chief Executive Officer and Expands Executive Team AstronauTx Ltd
01-Oct-2024 Nxera Pharma Enters New Commercial Partnership with Shionogi for QUVIVIQ™ in Japan Nxera Pharma
01-Oct-2024 Santhera Announces Positive Topline Results from LIONHEART Study with AGAMREE® (vamorolone) Demonstrating Unique Mineralocorticoid Receptor Antagonism Santhera Pharmaceuticals
01-Oct-2024 Tessellate BIO, Omico and CMRI announce a multi-year collaboration to accelerate discovery of synthetic lethal precision therapies to address ‘ALT’ cancers Tessellate BIO
01-Oct-2024 PureTech to Present at CHEST 2024 Annual Meeting PureTech Health
01-Oct-2024 Beckman Coulter Life Sciences Names Joe Fox President Beckman Coulter Life Sciences
01-Oct-2024 Eligo welcomes genetic medicines leader Bobby Gaspar as chair of its board of directors Andrew Lloyd Associates
01-Oct-2024 CSL Behring granted positive reimbursement recommendation for Haemophilia B Gene Therapy, HEMGENIX® in Spain CSL Behring
01-Oct-2024 Ablation Technologies Market Size to Hit USD 13903 Million by 2032 Driven By Growing Demand For Minimally Invasive Treatment - Acumen Research And Consulting Acumen Research And Consulting
01-Oct-2024 Lynred demonstrates smallest thermal imaging sensor for future AutomaticEmergency Braking Systems (AEB) at AutoSens Europe Andrew Lloyd Associates
29-Sep-2024 Brief discussion on the development and course of plant extract in China Xuancheng Quality Herb Co.,ltd
27-Sep-2024 Dupixent approved in the US as the first-ever biologic medicine for patients with COPD Sanofi